Unlocking glioma genetics with deep learning.

Journal: Med (New York, N.Y.)
Published Date:

Abstract

The AI era in medicine has ushered in new opportunities to improve the diagnosis and treatment of human disease. CHARM, an AI algorithm described in this issue, has the potential to streamline molecular classification, intraoperative diagnosis, surgical decision making, and trial enrollment for glioma patients.

Authors

  • Daniel A Orringer
    Departments of1Neurosurgery.
  • Todd C Hollon
    Departments of1Neurosurgery.